Elevated σ2R levels are found in lung tumors and plasma from patients with lung cancer (24), and preclinical evidence suggests that σ2R may be a therapeutic target as σ2R ligands potentiate the efficacy of chemotherapeutic agents in mouse models of pancreatic cancer and improve survival (25–27). The gene discussed is TMEM97; the disease is lung cancer.